TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Psyence BioMed CEO Letter Highlights Clinical Progress, Ethical Sourcing of Ibogaine, Strong Cash Position and Expanding Leadership in Longevity Science

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Jody Aufrichtig
Psyence BioMed CEO Letter Highlights Clinical Progress, Ethical Sourcing of Ibogaine, Strong Cash Position and Expanding Leadership in Longevity Science

Psyence BioMed advanced its Phase IIb clinical trial for psilocybin-assisted psychotherapy in palliative care, secured nature-derived psilocybin and ibogaine supply, and positioned itself as a leader in longevity science research.

Insights
AAPL   negative

Part of the Magnificent Seven group that lost significant market value


PBM   positive

Company demonstrated significant clinical progress, secured manufacturing capabilities, ended the year debt-free with $9 million in cash reserves, and expanded into innovative longevity science research